about
Long-term outcome of conservatively treated patients with borderline coronary lesions--role of the fractional flow reserve measurementBorderline coronary lesions may lead to serious coronary events--long-term outcome in 65 conservatively treated patientsIdentification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and cardiologists in contemporary Poland: the results from the DATA-HELP registry.Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants.Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormonesClinical profile and management of outpatients with non-ischemic and non-hypertensive systolic heart failure: Analysis of the Polish DATA-HELP registry.Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study.Iron status in patients with chronic heart failure.Percutaneous reduction of mitral valve regurgitation using the MitraClip system - immediate and 90-day follow-up of 3 cases.POL-TAVI - Polish Registry of Transcatheter Aortic Valve Implantation - simple tool, great value, rationale and design.Does right ventricular pacing increase the risk of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator?Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.Iron deficiency and red cell indices in patients with heart failure.Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure.Could an analysis of mean corpuscular volume help to improve risk stratification in non-anemic patients with acute myocardial infarction?Sexual dimorphism in socioeconomic differences regarding the risk factors, symptomatology and management of patients with stable coronary artery disease in Poland.Circulating estradiol and mortality in men with systolic chronic heart failure.[Assessment of the functioning of autonomic nervous system in the context of cardiorespiratory reflex control].Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure.Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.Ferric carboxymaltose in patients with heart failure and iron deficiency.Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.[A 67-year-old men with not corrected tetralogy of Fallot].Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure.[Early bioprosthetic mitral valve thrombosis].The association of lower testosterone level with coronary artery disease in postmenopausal women.[Heart rate profile: from physiology to clinical practice].Measurement of coronary fractional flow reserve. Standard doses of intracoronary adenosine are insufficient to induce maximal hyperaemia.[Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report].Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.[Arterial baroreflex--physiological role and assessment of functioning].[Intracardiac thrombi in pulmonary embolism of a priori non high risk: therapeutic dilemma].Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.Iron deficiency in chronic heart failure: an international pooled analysis.Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure.
P50
Q28173899-1D680D34-B3CA-4574-B4C4-ED60D4D85495Q28190219-5D9B7715-8867-4473-A639-DFA9A270FCACQ28743491-9776C81E-7E78-41C2-A202-88236743A0C5Q30844914-B42EF78B-947C-4F5C-B45B-8853DA9CAB5FQ33400217-ECE30067-926A-4394-AD83-B29E30943F7FQ33700880-1191E73C-C688-4BDD-8BBD-7C53CE0DCDC6Q34590954-52F7DB5A-7FB3-4BAB-AC65-DFA7811E7DF6Q36341910-69998FCD-3B85-4A14-A376-DA8D5072FEBFQ36397578-41D217B5-1B8F-4698-8254-7EC247A99873Q36883631-00FD8173-BF54-44F0-8CB1-8243C57A3D99Q36971596-F01BD465-D6A9-4335-893B-B175C2687531Q37561866-FD30F41F-221A-4132-AFD1-4F8FA4392F66Q37584154-E8F9FB33-EC41-4E04-B4E4-98F59F3778C3Q38204724-4467C7F8-933B-4E37-A9EB-D4F068D03A89Q38715116-CB6D3547-F50F-49A9-A01E-8CFB06F04C6DQ38848629-3D08D7C0-C150-4032-BAC0-1510CCAB206EQ40395551-A233F8A7-2B0C-4823-AD1C-AB5E2981869AQ40810094-6FB565CF-DCCA-4307-B19C-5545FC875F11Q41197282-9E25DEB9-2A6D-4AB6-8027-089CB170E495Q42164921-1A7CC709-A321-4DD3-8F5D-5F26D9739930Q42929550-C4445741-5955-4472-93D3-AF3CA6260AEBQ42994571-90DD0C1F-8337-49A3-ADC2-F04A826829B9Q43136870-3ECA4336-54EB-457B-863B-E9E9437FBD24Q43240282-468DD423-7A18-4C42-977B-D2FDD78DE964Q43418400-09CE0388-6361-41A4-B487-81ECAD030FE2Q43559053-4F226850-B95A-41D2-AB32-844D3C85E2F1Q43942621-671CD6A1-DDEB-4FDF-90E5-A5ED9C33B876Q44132921-E26976A3-9926-43F0-A8C8-4229975AF45CQ44240010-9759E88F-911F-496D-B488-12F93D63251DQ44289464-ABB68203-B727-4F68-8E39-069199585A13Q44601272-6770D15C-3258-4347-9B23-E90BCEEF3B02Q44764167-51A984E1-3018-4C90-A3FF-D5CD967A9B87Q45158750-7D19EDDC-1DD4-4920-93FB-A8895EE87DCDQ45227776-B1627935-09FD-4298-9923-304303E18C5CQ45304989-96F3C322-DF80-46DE-B48B-A26479169981Q45992143-C7E6980E-CD3D-4F5A-B5FF-CDEDD2816751Q46036392-22F0A946-506D-4206-A50F-76F10F1EF7CEQ46257022-1DEA4A46-A250-4B0E-8B09-3CEAE9F6577CQ46398703-B8BA96BF-BF6E-4521-9BB6-9AE6EB86FC3FQ46407510-1C2CDE44-433D-42DB-A982-45A065026D38
P50
description
Polish cardiologist
@en
Pools arts
@nl
polski lekarz, kardiolog
@pl
name
Waldemar Banasiak
@ast
Waldemar Banasiak
@ca
Waldemar Banasiak
@cs
Waldemar Banasiak
@en
Waldemar Banasiak
@es
Waldemar Banasiak
@gl
Waldemar Banasiak
@hr
Waldemar Banasiak
@hsb
Waldemar Banasiak
@it
Waldemar Banasiak
@nl
type
label
Waldemar Banasiak
@ast
Waldemar Banasiak
@ca
Waldemar Banasiak
@cs
Waldemar Banasiak
@en
Waldemar Banasiak
@es
Waldemar Banasiak
@gl
Waldemar Banasiak
@hr
Waldemar Banasiak
@hsb
Waldemar Banasiak
@it
Waldemar Banasiak
@nl
prefLabel
Waldemar Banasiak
@ast
Waldemar Banasiak
@ca
Waldemar Banasiak
@cs
Waldemar Banasiak
@en
Waldemar Banasiak
@es
Waldemar Banasiak
@gl
Waldemar Banasiak
@hr
Waldemar Banasiak
@hsb
Waldemar Banasiak
@it
Waldemar Banasiak
@nl
P214
P106
P1412
P1559
Waldemar Banasiak
@pl
P21
P214
P27
P31
P3124
P734
P735
P7859
viaf-101942228